Murtezani A. Comparison of Clinical Effectiveness of Folfirinox versus Gemcitabine on Quality of Life in Patients with Pancreatic Cancer Stage IV. AJP [Internet]. 2017 Oct. 11 [cited 2025 Nov. 9];11(03). Available from: https://asiapharmaceutics.info/index.php/ajp/article/view/1468